(firstQuint)A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402.

 This study is designed as randomized, open-label, active-controlled and crossover assignment for evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects.

 The safety assessed through adverse events up to 17 days after administration.

 Additional variables (ECGs, laboratory test, vital signs, so on) will also be recorded and assessed.

.

 A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402@highlight

The purpose of this study is to evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects.

